Marty Makary: FDA Has Published More than 200 Complete Response Letters
Marty Makary, 27th Commissioner of the U.S. FDA, shared a post on LinkedIn:
“Today, we’re delivering on our promise of radical transparency. The FDA just published 200+ complete response letters – the actual decision letters we send to drug companies when applications need more work. No more guessing games. Developers, investors, and patients deserve to see how we make decisions.
For decades, the same regulatory mistakes have been repeated because lessons from FDA rejections stayed hidden. Today, we published our complete response letters so the entire industry can learn from each other’s missteps. Predictability accelerates cures.”
FDA shared this post, adding:
“Today, the FDA published more than 200 decision letters, known as complete response letters or CRLs. Important update!”
More posts featuring Marty Makary and FDA.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023